The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications

Background and Objectives: Non-selective β-blockers (NSBB) could prevent decompensation and hepatocellular carcinoma (HCC) in cirrhotic patients with clinically significant portal hypertension (CSPH), but remained uncertain for compensated cirrhotic patients without major complications. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Wen-Shuo, Yang, Shih-Cheng, Liang, Chih-Ming, Li, Yu-Chi, Tai, Wei-Chen, Lee, Chen-Hsiang, Yang, Yao-Hsu, Hsu, Chien-Ning, Tsai, Tzu-Hsien, Chuah, Seng-Kee, Wu, Cheng-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022668/
https://www.ncbi.nlm.nih.gov/pubmed/31905956
http://dx.doi.org/10.3390/medicina56010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022668/
https://www.ncbi.nlm.nih.gov/pubmed/31905956
http://dx.doi.org/10.3390/medicina56010014

Ejemplares similares